307 related articles for article (PubMed ID: 26124281)
1. SRSF2 Is Essential for Hematopoiesis, and Its Myelodysplastic Syndrome-Related Mutations Dysregulate Alternative Pre-mRNA Splicing.
Komeno Y; Huang YJ; Qiu J; Lin L; Xu Y; Zhou Y; Chen L; Monterroza DD; Li H; DeKelver RC; Yan M; Fu XD; Zhang DE
Mol Cell Biol; 2015 Sep; 35(17):3071-82. PubMed ID: 26124281
[TBL] [Abstract][Full Text] [Related]
2. Physiological
Kon A; Yamazaki S; Nannya Y; Kataoka K; Ota Y; Nakagawa MM; Yoshida K; Shiozawa Y; Morita M; Yoshizato T; Sanada M; Nakayama M; Koseki H; Nakauchi H; Ogawa S
Blood; 2018 Feb; 131(6):621-635. PubMed ID: 29146882
[TBL] [Abstract][Full Text] [Related]
3. SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells.
Liang Y; Tebaldi T; Rejeski K; Joshi P; Stefani G; Taylor A; Song Y; Vasic R; Maziarz J; Balasubramanian K; Ardasheva A; Ding A; Quattrone A; Halene S
Leukemia; 2018 Dec; 32(12):2659-2671. PubMed ID: 29858584
[TBL] [Abstract][Full Text] [Related]
4.
Smeets MF; Tan SY; Xu JJ; Anande G; Unnikrishnan A; Chalk AM; Taylor SR; Pimanda JE; Wall M; Purton LE; Walkley CR
Blood; 2018 Aug; 132(6):608-621. PubMed ID: 29903888
[TBL] [Abstract][Full Text] [Related]
5. Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins.
Lee SC; Dvinge H; Kim E; Cho H; Micol JB; Chung YR; Durham BH; Yoshimi A; Kim YJ; Thomas M; Lobry C; Chen CW; Pastore A; Taylor J; Wang X; Krivtsov A; Armstrong SA; Palacino J; Buonamici S; Smith PG; Bradley RK; Abdel-Wahab O
Nat Med; 2016 Jun; 22(6):672-8. PubMed ID: 27135740
[TBL] [Abstract][Full Text] [Related]
6. Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome.
Colla S; Ong DS; Ogoti Y; Marchesini M; Mistry NA; Clise-Dwyer K; Ang SA; Storti P; Viale A; Giuliani N; Ruisaard K; Ganan Gomez I; Bristow CA; Estecio M; Weksberg DC; Ho YW; Hu B; Genovese G; Pettazzoni P; Multani AS; Jiang S; Hua S; Ryan MC; Carugo A; Nezi L; Wei Y; Yang H; D'Anca M; Zhang L; Gaddis S; Gong T; Horner JW; Heffernan TP; Jones P; Cooper LJ; Liang H; Kantarjian H; Wang YA; Chin L; Bueso-Ramos C; Garcia-Manero G; DePinho RA
Cancer Cell; 2015 May; 27(5):644-57. PubMed ID: 25965571
[TBL] [Abstract][Full Text] [Related]
7. SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition.
Kim E; Ilagan JO; Liang Y; Daubner GM; Lee SC; Ramakrishnan A; Li Y; Chung YR; Micol JB; Murphy ME; Cho H; Kim MK; Zebari AS; Aumann S; Park CY; Buonamici S; Smith PG; Deeg HJ; Lobry C; Aifantis I; Modis Y; Allain FH; Halene S; Bradley RK; Abdel-Wahab O
Cancer Cell; 2015 May; 27(5):617-30. PubMed ID: 25965569
[TBL] [Abstract][Full Text] [Related]
8. Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo.
Shirai CL; Ley JN; White BS; Kim S; Tibbitts J; Shao J; Ndonwi M; Wadugu B; Duncavage EJ; Okeyo-Owuor T; Liu T; Griffith M; McGrath S; Magrini V; Fulton RS; Fronick C; O'Laughlin M; Graubert TA; Walter MJ
Cancer Cell; 2015 May; 27(5):631-43. PubMed ID: 25965570
[TBL] [Abstract][Full Text] [Related]
9. Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities.
Zhang J; Lieu YK; Ali AM; Penson A; Reggio KS; Rabadan R; Raza A; Mukherjee S; Manley JL
Proc Natl Acad Sci U S A; 2015 Aug; 112(34):E4726-34. PubMed ID: 26261309
[TBL] [Abstract][Full Text] [Related]
10. Effect of RNA splicing machinery gene mutations on prognosis of patients with MDS: A meta-analysis.
Wang X; Song X; Yan X
Medicine (Baltimore); 2019 May; 98(21):e15743. PubMed ID: 31124956
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the Spliceosomal Machinery Genes SRSF2, U2AF1, and ZRSR2 and Response to Decitabine in Myelodysplastic Syndrome.
Hong JY; Seo JY; Kim SH; Jung HA; Park S; Kim K; Jung CW; Kim JS; Park JS; Kim HJ; Jang JH
Anticancer Res; 2015 May; 35(5):3081-9. PubMed ID: 25964599
[TBL] [Abstract][Full Text] [Related]
12. Recurrent SRSF2 mutations in MDS affect both splicing and NMD.
Rahman MA; Lin KT; Bradley RK; Abdel-Wahab O; Krainer AR
Genes Dev; 2020 Mar; 34(5-6):413-427. PubMed ID: 32001512
[TBL] [Abstract][Full Text] [Related]
13. Myelodysplasia-associated mutations in serine/arginine-rich splicing factor SRSF2 lead to alternative splicing of CDC25C.
Skrdlant L; Stark JM; Lin RJ
BMC Mol Biol; 2016 Aug; 17(1):18. PubMed ID: 27552991
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of splicing machinery genes SF3B1, U2AF1 and SRSF2 in myelodysplasia and other common tumors.
Je EM; Yoo NJ; Kim YJ; Kim MS; Lee SH
Int J Cancer; 2013 Jul; 133(1):260-5. PubMed ID: 23280334
[TBL] [Abstract][Full Text] [Related]
15. Development of a high-resolution melting curve analysis screening test for SRSF2 splicing factor gene mutations in myelodysplastic syndromes.
Garza E; Fabiani E; Noguera N; Panetta P; Piredda ML; Borgia L; Maurillo L; Catalano G; Voso MT; Lo-Coco F
J Mol Diagn; 2015 Jan; 17(1):85-9. PubMed ID: 25445211
[TBL] [Abstract][Full Text] [Related]
16. Detection of SRSF2-P95 mutation by high-resolution melting curve analysis and its effect on prognosis in myelodysplastic syndrome.
Lin J; Yang J; Wen XM; Yang L; Deng ZQ; Qian Z; Ma JC; Guo H; Zhang YY; Qian W; Qian J
PLoS One; 2014; 9(12):e115693. PubMed ID: 25541999
[TBL] [Abstract][Full Text] [Related]
17. Charting the "Splice" Routes to MDS.
Obeng EA; Ebert BL
Cancer Cell; 2015 May; 27(5):607-9. PubMed ID: 25965565
[TBL] [Abstract][Full Text] [Related]
18. [Mutational analysis of RNA splicing machinery genes SF3B1, U2AF1 and SRSF2 in 118 patients with myelodysplastic syndromes and related diseases].
Wang JY; Ma J; Lin YN; Wang J; Shen H; Gui FM; Han C; Li QH; Song Z; Wang XJ
Zhonghua Xue Ye Xue Za Zhi; 2017 Mar; 38(3):192-197. PubMed ID: 28395441
[No Abstract] [Full Text] [Related]
19. Srsf2
Xu JJ; Chalk AM; Wall M; Langdon WY; Smeets MF; Walkley CR
Leukemia; 2022 Dec; 36(12):2883-2893. PubMed ID: 36271153
[TBL] [Abstract][Full Text] [Related]
20. The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts.
Kang MG; Kim HR; Seo BY; Lee JH; Choi SY; Kim SH; Shin JH; Suh SP; Ahn JS; Shin MG
BMC Cancer; 2015 Jun; 15():484. PubMed ID: 26115659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
